We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
-5.44%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.06B
AUM Growth
-$215M
(-4.1%)
Cap. Flow
-$288M
Cap. Flow
% of AUM
-5.68%
Top 10 Holdings %
Top 10 Hldgs %
52.55%
Holding
152
New
45
Increased
20
Reduced
17
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$94.3M |
| 2 |
Pfizer
PFE
|
+$87.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$79.4M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$38.7M |
| 5 |
Insmed
INSM
|
+$35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WAY
Waystar Holding Corp
WAY
|
+$121M |
| 2 |
ACH
Accendra Health
ACH
|
+$64.2M |
| 3 |
Alignment Healthcare
ALHC
|
+$40.8M |
| 4 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$38.8M |
| 5 |
BCAX
Bicara Therapeutics
BCAX
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.22% |
| 2 | Real Estate | 0.01% |
| 3 | Technology | 0.01% |
| 4 | Consumer Discretionary | 0.01% |
| 5 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
BiomX
PHGE
$1.98M
| $1.39M | 0.03% |
131,269
+37,184
| +40% | +$519K |
|
77
Alector
ALEC
$169M
| $1.3M | 0.03% |
1,055,192
-11,770
| -1% | -$19.2K |
|
78
Annexon
ANNX
$814M
| $1.13M | 0.02% |
583,913
| – | – |
|
79
Twist Bioscience
TWST
$5.51B
| $935K | 0.02% |
23,827
| – | – |
|
80
NewAmsterdam Pharma Warrant
NAMSW
$76.2M
| $834K | 0.02% |
92,787
| – | – |
|
81
Humana
HUM
$46.7B
| $243K | ﹤0.01% |
917
| – | – |
|
82
St. Joe Company
JOE
$3.57B
| $210K | ﹤0.01% |
+4,473
| New | +$209K |
|
83
DXC Technology
DXC
$1.76B
| $203K | ﹤0.01% |
+11,883
| New | +$231K |
|
84
Xponential Fitness
XPOF
$282M
| $192K | ﹤0.01% |
+23,097
| New | +$322K |
|
|
FPI
85
Farmland Partners
FPI
$417M
| $188K | ﹤0.01% |
+16,863
| New | +$194K |
|
86
Hallador Energy
HNRG
$689M
| $168K | ﹤0.01% |
+13,713
| New | +$154K |
|
87
Ring Energy
REI
$287M
| $146K | ﹤0.01% |
+127,376
| New | +$166K |
|
|
QSIAW
88
DELISTED
Quantum-Si Inc Warrant
QSIAW
| $133K | ﹤0.01% |
333,333
| – | – |
|
|
MFA
89
MFA Financial
MFA
$935M
| $112K | ﹤0.01% |
+10,935
| New | +$114K |
|
90
Petco
WOOF
$811M
| $108K | ﹤0.01% |
+35,446
| New | +$111K |
|
91
Backblaze
BLZE
$724M
| $104K | ﹤0.01% |
+21,475
| New | +$132K |
|
92
Vir Biotechnology
VIR
$1.49B
| $102K | ﹤0.01% |
+15,728
| New | +$140K |
|
93
MediaAlpha
MAX
$746M
| $99.7K | ﹤0.01% |
+10,795
| New | +$115K |
|
94
MannKind Corp
MNKD
$1.21B
| $87.4K | ﹤0.01% |
+17,380
| New | +$97.4K |
|
|
DHC
95
Diversified Healthcare Trust
DHC
$2.23B
| $81.3K | ﹤0.01% |
33,892
+18,047
| +114% | +$44.5K |
|
96
Zevra Therapeutics
ZVRA
$575M
| $81.3K | ﹤0.01% |
+10,849
| New | +$86.2K |
|
97
Nuvation Bio
NUVB
$2.33B
| $80K | ﹤0.01% |
45,448
+25,282
| +125% | +$57.5K |
|
98
Repay Holdings
RPAY
$344M
| $73.4K | ﹤0.01% |
+13,175
| New | +$90.6K |
|
99
Quanterix
QTRX
$164M
| $71.8K | ﹤0.01% |
+11,023
| New | +$92K |
|
100
Absci
ABSI
$1.21B
| $70.5K | ﹤0.01% |
+28,071
| New | +$103K |
|
Similar funds
FT
GRQ
PCM
VA
QC
IC
NW
AAF
Deerfield Management's Q1 2025 Portfolio in Review
As of Q1 2025, Deerfield Management held 152 positions worth $5.06B, down 4.1% from $5.28B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Deerfield Management withdrew a net $288M in Q1 2025, closing 29 positions and reducing 17 holdings. Its most notable exit was Waystar Holding Corp, an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 88% a quarter earlier, followed by Real Estate and Technology.
Against the trend, Deerfield Management opened a new position in United Therapeutics worth $84.8M.
- Deerfield Management's largest Q1 2025 buy was United Therapeutics: 275,226 shares worth $84.8M.
- Deerfield Management added most to Neurocrine Biosciences in Q1 2025, an estimated $79.4M increase.
- Deerfield Management's biggest Q1 2025 reduction was Alignment Healthcare, cutting an estimated $40.8M.
- Deerfield Management fully exited Waystar Holding Corp in Q1 2025, selling an estimated $121M.
- Deerfield Management's ten largest holdings make up 53% of its $5.06B portfolio in Q1 2025.
- Deerfield Management opened 45 new positions and closed 29 in Q1 2025.
- Deerfield Management's portfolio value fell 4.1% quarter-over-quarter to $5.06B.
Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.